ISSN 1016-5169 | E-ISSN 1308-4488
Archives of the Turkish Society of Cardiology
Polypharmacy and drug interactions in elderly patients [Turk Kardiyol Dern Ars]
Turk Kardiyol Dern Ars. 2017; 45(5): 17-21 | DOI: 10.5543/tkda.2017.92770

Polypharmacy and drug interactions in elderly patients

Aytül Belgi Yıldırım, Ali Yaşar Kılınç
Department of Cardiology, Akdeniz University Faculty of Medicine, Antalya, Turkey

Although the definition of polypharmacy is not yet clear today, it is generally regarded as drug use more than the patient needs. Advanced age is the most important risk factor for polypharmacy. In addition, other risk factors are loss of current cognitive functions, low socioeconomic level and nursing care. It is seen in about 40% of people over 75 years of age worldwide, varying between countries of extreme poverty. Incorrect drug use, drug side effects and drug-drug interaction lead to unwanted hospitalizations. In particular, cardiovascular drugs pose risks in terms of drug side effects in advanced ages. Altering the pharmacokinetics and pharmacodynamics of the drug along with advanced age lead to more frequent side effects or no effect of the drugs. The most important point to prevent polypharmacy is to inform the patient or the patient’s caregiver fully and to target treatment with a minimum number of drugs and doses.

Keywords: Drug interaction, elderly patients, polyparmacy.

How to cite this article
Aytül Belgi Yıldırım, Ali Yaşar Kılınç. Polypharmacy and drug interactions in elderly patients. Turk Kardiyol Dern Ars. 2017; 45(5): 17-21

Corresponding Author: Aytül Belgi Yıldırım, Türkiye
Manuscript Language: Turkish


Journal Metrics

Journal Citation Indicator: 0.18
CiteScore: 1.1
Source Normalized Impact
per Paper:
0.22
SCImago Journal Rank: 0.348

Quick Search



Copyright © 2024 Archives of the Turkish Society of Cardiology



Kare Publishing is a subsidiary of Kare Media.